Roche Holding AG
- Country
- 🇨🇭Switzerland
- Ownership
- Public
- Established
- 1896-01-15
- Employees
- 103.6K
- Market Cap
- $270.5B
- Website
- http://www.roche.com
- Introduction
Roche is a Swiss biopharmaceutical and diagnostic company. The firm's bestselling pharmaceutical products include a variety of oncology therapies from acquired partner Genentech, and its diagnostics group was bolstered by the acquisition of Ventana in 2008. Oncology products account for 50% of pharmaceutical sales, and centralized and point-of-care diagnostics for more than half of diagnostic-related sales.
A Study of Monthly Subcutaneous or Intravenous Mircera in Dialysis Patients With Chronic Renal Anaemia
- Conditions
- Anemia
- Interventions
- Procedure: DialysisDrug: methoxy polyethylene glycol-epoetin beta [Mircera]
- First Posted Date
- 2010-07-02
- Last Posted Date
- 2015-12-03
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 86
- Registration Number
- NCT01156363
A Study of Induction and Maintenance Treatment With MabThera (Rituximab) in Patients With Indolent B-Cell Nonfollicular Lymphomas
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2017-08-01
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 47
- Registration Number
- NCT01153971
- Locations
- 🇮🇹
Universita' Degli Studi La Sapienza-Ist.Di Ematologia;Dip. Biotecnologie Cel CELLULARI ED EMATOLOGIA, Roma, Lazio, Italy
🇮🇹Ospedale Civile; Divisione Di Oncologia, Pescara, Abruzzo, Italy
🇮🇹A.O.U. Policlinico di Modena-Dipartimento di Medicina Diagnostica, Clinica e di Sanità pubblica, Modena, Emilia-Romagna, Italy
A Study to Assess Biomarkers Impact on Participants Response to Erlotinib Treatment for First-line Non-Small Cell Lung Cancer With Endothelial Growth Factor Receptor (EGFR) Activating Mutations
- First Posted Date
- 2010-06-30
- Last Posted Date
- 2017-04-13
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 23
- Registration Number
- NCT01153984
- Locations
- 🇷🇴
Spitalul de Boli Cronice Sf. Luca, Bucharest, Romania
🇷🇴Emergency University Bucharest Hospital; Oncology Department, Bucharest, Romania
🇷🇴ONCOMED - Medical Centre, Timisoara, Romania
A Study of RO5024048 in Japanese and Caucasian Healthy Volunteers
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 97
- Registration Number
- NCT01152671
A Study of Cardiac Safety in Patients With HER2 Positive Early Breast Cancer Treated With Herceptin
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2018-01-25
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 3942
- Registration Number
- NCT01152606
- Locations
- 🇦🇹
Lkh-Univ. Klinikum Graz; Klinik Für Gynäkologie, Graz, Austria
🇦🇹LKH-UNIV. KLINIKUM GRAZ; Klinische Abteilung für Onkologie, Graz, Austria
🇦🇹LKH Hochsteiermark; Abt. für Innere Medizin, Leoben, Austria
A Study of RO4989991 in Patients With Allergic Rhinitis
- First Posted Date
- 2010-06-29
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 24
- Registration Number
- NCT01152619
A Study of RoActemra/Actemra (Tocilizumab) in Patients With Active Rheumatoid Arthritis Who Have an Inadequate Response to Current Non-Biologic and/or Biologic DMARDS
- First Posted Date
- 2010-06-23
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 145
- Registration Number
- NCT01149057
A Dose-finding Study of RO5323441 in Patients With Metastatic Treatment-Refractory Colorectal or Ovarian Cancer
- First Posted Date
- 2010-06-22
- Last Posted Date
- 2016-11-02
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 7
- Registration Number
- NCT01148758
A Study of MabThera (Rituximab) in Elderly Patients With Untreated Follicular Non-Hodgkin's Lymphoma (NHL)
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2017-08-15
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 234
- Registration Number
- NCT01144364
- Locations
- 🇮🇹
Dept. Medicina Clinica E Sperimentale; Sez. Medicina Interna E Scienze Oncologiche - Pol. Monteluce, Perugia, Umbria, Italy
🇮🇹ASST PAPA GIOVANNI XXIII; Ematologia, Bergamo, Lombardia, Italy
🇮🇹Ospedale S. Eugenio; Divisione Di Ematologia, Roma, Lazio, Italy
A Study of MabThera (Rituximab) Addition to Regularly Prescribed Chemotherapy in Patients With Untreated Mantle Cell Lymphoma.
- Conditions
- Diffuse Large B-Cell Lymphoma
- Interventions
- First Posted Date
- 2010-06-15
- Last Posted Date
- 2016-10-18
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 8
- Registration Number
- NCT01144403